On September 19, Menarini Silicon Biosystems announced the launch of new cloud-based data analysis solution, MSBiosuite. MSBiosuite automated data analysis platform processes NGS data generated from research in liquid biopsy area and formalin-fixed paraffin embedded (FFPE) tissue analysis.
NGS Data Analysis Made Easy Through Menarini’s Cloud Based ‘Msbiosuite Bioinformatic Platform’
Posted by
MarketsandMarkets on Oct 1, 2019 3:03:49 PM
0 Comments Click here to read/write comments
Topics: healthcare, Liquid Biopsy Market, Menarini Silicon, Next-generation sequencing (NGS)